From the I Clinica Medica, University of Pisa, Italy.
Correspondence to Dr Stefano Taddei, I Clinica Medica, University of Pisa, Via Roma 67, 56100 Pisa, Italy. E-mail s.taddei{at}int.med.unipi.it
It is well documented that functional or morphological alterations of
endothelial cells appear to be critical to the
evolution, progression, and clinical manifestation of atherosclerotic
vascular disease.2 3 In addition,
endothelial dysfunction has been documented in the
presence of atherosclerotic lesions,4 and it
predicts the development of atherosclerotic lesions in epicardial
vessels of cardiac transplant patients.5
Moreover, endothelial dysfunction has also been
documented in the presence of different cardiovascular
risk factors involved in the pathogenesis of
atherosclerosis itself, such as
hypertension,6 7 8 9
aging,9 10 menopause,10
hypercholesterolemia,11 12
diabetes mellitus,13 14 and
smoking.15
In recent years, ultrasound imaging of the extracranial carotid
arteries has been extensively used to detect early arterial
wall abnormalities. Moreover, IMT of the carotid wall has been
considered an early marker of
atherosclerosis16 and a possible
index of coronary artery
atherosclerosis.17
The aim of the present study was to evaluate the relation between
carotid wall IMT with different functional and structural
cardiovascular parameters and humoral
factors in patients with essential hypertension. Moreover, to better
clarify the link between essential hypertension and induction of
atherosclerosis, we avoided confounding factors, such
as previous pharmacological antihypertensive treatment or the
frequently encountered impossibility of ascertaining the duration of
hypertensive disease. Therefore, in the present study, we selected
only those patients who had never been treated and who had a documented
history of essential hypertension no longer than 12 months.
Essential hypertension patients were recruited with the collaboration
of 10 general practitioners working in the city of Pisa.
The practitioners were asked to enroll patients with
recent-onset essential hypertension (no more than 12 months). It is
worth noting that patients were enrolled only if they reported a
history of periodic BP measurements. This criterion excluded the
possibility of detecting hypertension that corresponded to the first BP
measurement in a patient's life, which would have led to difficulty in
ascertaining the time of onset of hypertensive disease. In all cases,
subjects were characterized by the presence of a positive family
history of essential hypertension and a supine arterial BP
(after 10 minutes of rest) consistently >140/90 mm Hg,
as measured by mercury sphygmomanometer three times at 1-week
intervals. Secondary forms of hypertension were excluded as follows:
renovascular disease was excluded in most cases by renal artery color
Doppler echography, whereas in 16 of 44 patients, renal angiography
was performed; renal parenchymal diseases was ruled out by the
normality of serum creatinine levels, urine examination,
and renal echotomography; primary aldosteronism was ruled out by the
absence of hypokalemia and the normality of plasma renin activity and
aldosterone; pheochromocytoma was ruled out by the
normality of plasma catecholamine levels and the absence of
an adrenal or abdominal mass on echotomography. Mean age was 45.7±8.8
years (range, 28 to 60 years). BP values were
158.8±13.2/101.7±6.9 mm Hg. As control subjects, 30 healthy
normotensive volunteers (mean±SD age, 44.7±6.6 years; mean±SD BP,
116.8±3.6/75.4±4.1 mm Hg) were enrolled.
Drugs
Experimental Procedures
Carotid Artery B-Mode Ultrasound Imaging
Patients with an IMT <1 mm were considered normal, patients with
an IMT between 1 and 1.3 mm were considered to have wall
thickening, and patients with an IMT >1.3 mm were considered to
have plaque.18 19 The operator (L.D.V.) was
blinded with respect to the results of other evaluations.
Echocardiographic Evaluation
FBF Studies
Forearm volume was measured according to the water-displacement method,
and drug infusion rates were normalized for 1 dL of tissue by adjusting
the concentration of the stock solution to the desired infusion rate.
Drugs were infused at systemically ineffective rates through separate
ports via three-way stopcocks. The operator (A.V.) was blinded with
respect to the results of other evaluations.
Endothelium-dependent vasodilation was estimated by
performing a dose-response curve to intra-arterial Ach
(cumulative increase of the infusion rates were 0.15, 0.45, 1.5, 4.5,
and 15 µg per 100 mL of forearm tissue per minute for 5 minutes at
each dose). Endothelium-independent vasodilation was
assessed with a dose-response curve to intra-arterial SNP,
a direct smooth muscle cell relaxant compound,23
(cumulative increase by 1, 2, and 4 µg per 100 mL of forearm tissue
per minute for 5 minutes at each dose). These rates were selected to
induce vasodilation comparable to that obtained with Ach.
MFVRs were calculated as the ratio between maximal
postischemic FBF increase (after 13 minutes of
ischemia plus 1 minute of dynamic hand exercise) and
intra-arterial mean arterial pressure, as
previously described.24 The sequence of the
experimental interventions was randomized, and a 45-minute recovery
period was allowed between the three experimental steps.
Data Analysis
Interactions between carotid wall thickening and forearm vasodilation
to Ach, SNP (considered as the maximum effect), age, BP, LVMI, MFVR,
plasma total cholesterol, and plasma HDL and LDL
cholesterol were calculated by both simple correlation and
multiple regression analyses.
Ach caused dose-dependent vasodilation, which was shown to be
significantly blunted in essential hypertension patients compared with
normotensive subjects (FBF rose from 3.4±0.5 to 24.8±4.8 and 3.5±0.4
to 35.1±7.1 mL per 100 mL of forearm tissue per minute, respectively;
P<0.001) (Figure 1
In essential hypertension patients, a significant inverse correlation
was found between carotid artery IMT and Ach-induced forearm
vasodilation, as evaluated in terms of FBF response to the highest
infusion rate of the agonist (15 µg per 100 mL of forearm tissue per
minute; r=-0.58, P=0.0003) (Figure 3
In addition, no correlation was observed between carotid artery IMT and
systolic (r=-0.05, P=NS) or
diastolic (r=-0.2, P=NS) BP.
However, when the data from essential hypertension patients were
considered together with data from normotensive subjects, a positive
correlation was observed between IMT and systolic
(r=0.39, P<0.001) and diastolic
(r=0.34, P<0.01) BP. Finally, no correlation was
observed between carotid IMT and MFVR (r=-0.2,
P=NS), LVMI (r=0.09, P=NS), total
cholesterol (r=-0.08, P=NS), HDL
cholesterol (r=0.003, P=NS), LDL
cholesterol (r=-0.04, P=NS), or
plasma glucose (r=-0.13, P=NS).
Finally, multivariate regression analysis
showed that the correlation between carotid IMT and the other
parameters (r2=0.51) was
influenced most by the maximal response to Ach
(r2=0.35) and age
(r2=0.15). When the effect of aging was
taken into account in the analysis, the relationship between
the response to Ach and carotid IMT remained statistically significant
(from P<0.004 to P<0.03).
Following these inclusion criteria, we selected a fairly
homogeneous study population represented by
never-treated essential hypertension patients with a short duration of
the disease. Moreover, apart from high BP, the hypertensive patients
studied were characterized by normal glucose and lipid profiles and a
moderate prevalence of smoking history. In line with previous
evidence,5 6 7 8 9 these patients showed
endothelial dysfunction because vasodilation to Ach but
not to SNP was found to be reduced compared with that of normotensive
control subjects. However, the interesting finding of the present
study is that when essential hypertension patients were divided into
three subgroups according to the different carotid IMT findings, the
response to Ach, while still impaired in patients with a normal IMT
compared with normotensive patients, showed a further significant
reduction in patients with thickening of the carotid artery and an even
greater reduction in patients with plaque. Because the vasodilating
effect of SNP proved to be similar in the three subgroups of
hypertensive patients, the present results indicate that IMT of the
extracranial carotid arterial wall is associated with
blunted endothelium-dependent vasodilation in essential
hypertension. This hypothesis is reinforced by the finding that in this
study population of essential hypertension patients, carotid IMT showed
a negative and significant correlation with maximal response to Ach but
not to SNP. In contrast, carotid IMT of the control subjects showed no
correlation with vasodilation to Ach.
Finally, in essential hypertension patients, the response to Ach was
not correlated with the calculated MFVR or LVMI, which are indexes of
arteriolar29 and cardiac28
structural alterations, respectively. Moreover, no correlation was
found between IMT of the carotid arteries and LVMI or MFVR.
These results suggest that in our study population of never-treated
essential hypertension patients with a relatively low
cardiovascular risk, there is a possible link between
endothelial dysfunction and early structural changes of
a large conduit artery, such as the carotid. On the other hand, the
lack of correlation between endothelial dysfunction and
MFVR or LVMI suggests that such alterations could be determined by
different mechanisms. This possibility is in agreement with the
evidence that blunted endothelium-dependent
vasodilation is a "primitive" phenomenon and not secondary to the
development of hypertension because this response is present in the
normotensive offspring of essential hypertension
patients,30 shows no significant correlation with
BP values,9 31 and is not reversed by BP
normalization.32 33 In contrast, cardiac and
microvascular structural alterations seem to be more closely related to
BP values.26 28
The lack of correlation between carotid IMT and LVMI is at variance
with previous reports.34 35 However, the
discrepancy can be explained by the fact that in the article by Roman
et al,34 the study population included both
normotensive and hypertensive patients in the analysis, with a
wide range of LVMI values. Moreover, the study of Cuspidi et
al35 also considered patients with concentric
remodeling.
Taken together, the present findings suggest that a dysfunctional
endothelium can be a predisposing factor to the
development of atherosclerosis. If this is the case, it
is worth noting that the subgroup of essential hypertension patients
with a normal carotid IMT was characterized by a response to Ach that
was significantly lower than that observed in normotensive controls. It
is therefore conceivable that a certain degree of
endothelial dysfunction is necessary to observe a
detectable association with atherosclerosis. However,
another possible explanation for the latter result could lie in the
major limitation of the present study, namely, the comparison of
two different vascular districts, the forearm and carotid vasculature,
with different structures (microcirculation and large arteries,
respectively). The forearm vasculature is not usually affected by
atherosclerosis; in addition, vascular reactivity in
the microcirculation is sometimes different from that observed in large
arteries.36 It is therefore crucial to avoid
conclusive statements, and further studies are needed to provide more
detailed confirmation of the association between
endothelial dysfunction and early development of
atherosclerosis in the carotid arteries.
The mechanism through which a dysfunctioning
endothelium could promote
atherosclerosis is related to the evidence that
endothelial dysfunction is caused by an alteration in
the L-arginineNO pathway,37 leading
to a reduction of NO bioavailability.38 NO
appears to be not only a potent vasodilator but also an
endogenous inhibitor of platelet
aggregation,39 vascular smooth muscle cell growth
and migration,40 41 leukocyte
adhesion,42 and adhesion molecule
expression.43 It is clear that an alteration in
the L-arginineNO pathway may reduce this potentially
antiatherosclerotic activity. In addition, a dysfunctional
endothelium can also produce prostanoids such as
thromboxane A2, which causes
vasoconstriction and platelet aggregation,44
and/or oxygen free radicals, which can destroy
NO45 and cause vascular
damage.46 Of relevance is the finding that
in the aorta and carotid artery of spontaneously hypertensive rats,
endothelial dysfunction is associated with
monocyte/macrophage infiltration,47
suggesting that endothelial activation could constitute
an early event in hypertension, leading to both increased monocyte
adherence and chemotaxis and abnormal production of
endothelium-derived constricting factors.
Alternatively, the monocytes/macrophages might themselves
secrete constricting factors or further activate
endothelial cells. In conclusion, it may be
suggested that in essential hypertension, the mechanisms causing
endothelial dysfunction can potentially lead to
atherosclerosis. This hypothesis seems to be confirmed
by the finding that an impairment in the NO system is not an exclusive
characteristic of essential hypertension.37 38 It
has also been demonstrated in the presence of the majority of
cardiovascular risk factors, such as
aging,48
hypercholesterolemia,12
diabetes,13 and smoking,15
all pathological conditions characterized by an increased
predisposition to the development of atherosclerosis.
As a final speculation, it is possible that the increased wall
thickness may impair diffusion of endothelial
vasoactive substances to smooth muscle cells, thereby impairing
endothelium-dependent vasodilation. However, this
hypothesis seems to be indirectly excluded by the results with SNP.
This compound acts directly on smooth muscle as NO source cells, and no
different effect was observed in normotensive subjects or essential
hypertension patients with normal IMT compared with
hypertensive patients with plaque.
Another major factor to be considered is the role of aging. The
present study confirms previous evidence indicating a positive
correlation between IMT of the carotid artery and
aging.34 36 There is also a well-documented
association between advancing age and impaired
endothelium-dependent
vasodilation.9 10 11 Thus, aging itself could be
the main phenomenon involved, leading in a parallel manner to both the
development of carotid structural alterations and impaired
endothelium-dependent vasodilation. An alternative
possibility is that the summation of the simultaneous
negative effects of aging and hypertension could result in more
pronounced impairment of endothelial function, thereby
leading to atherosclerosis. The consideration that our
study population was represented by essential hypertension
patients with very low cardiovascular risk points to
the possibility that aging could play a key role in explaining the
association between carotid artery structural alterations and
endothelial dysfunction. However, even after accounting
for the role of aging, the inverse relationship between the response to
Ach and IMT remained statistically significant.
Finally, in these essential hypertension patients, we found no
correlation between carotid IMT and other important
atherosclerosis risk factors, such as high BP and
unfavorable glucose and lipid profiles, a result that is at variance
with several previous observations.36 49 50 A
likely explanation could be the fact that, in accordance with the
enrollment criteria, the present study population was characterized
by the presence of high BP values as the only major
cardiovascular risk factor. Thus, glucose and lipid
profiles not only were within the normal range but also had a minimum
range of variation. Therefore, these experimental conditions are
probably inadequate to detect an association between these risk factors
and carotid IMT. This possibility is reinforced by the evidence that
analysis of the relationship between BP values and IMT in the
entire study population (normotensives plus hypertensives,
characterized by a larger range of BP values) showed a positive
correlation between the parameters considered.
In conclusion, the present study indicates an association between
carotid artery IMT and impaired endothelium-dependent
vasodilation. Whether these vascular alterations are casually
associated or indicate a causal relationship between
endothelial dysfunction and development of
atherosclerosis in essential hypertension remains to be
established.
Received January 19, 1998;
first decision February 2, 1998;
accepted February 11, 1998.
2.
Ross R. The pathogenesis of
atherosclerosis: an update. N Engl J
Med. 1986;314:488500.[Medline]
[Order article via Infotrieve]
3.
Chobanian A. Pathophysiology of
atherosclerosis. Am J Cardiol. 1992;70:3G7G.[Medline]
[Order article via Infotrieve]
4.
Yasue H, Matsuyama K, Matsuyama K, Okamura K, Morikami
Y, Ogawa H. Response of angiographically normal human coronary
arteries to intracoronary injection of acetylcholine by age and
segment: possible role of early coronary
atherosclerosis. Circulation. 1990;81:482490.
5.
Davis SF, Yeung AC, Meredith IT, Charbonneau F, Ganz
P, Selwyn P, Anderson TJ. Early endothelial dysfunction
predicts the development of transplant coronary artery disease
at 1 year post transplant. Circulation. 1996;93:457462.
6.
Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect
evidence for the release of endothelium-derived
relaxing factor in the human forearm circulation in vivo: blunted
response in essential hypertension. Circulation. 1990;81:17621767.
7.
Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE.
Abnormal endothelium dependent vascular relaxation in
patients with essential hypertension. N Engl J
Med. 1990;323:2227.[Abstract]
8.
Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation
to acetylcholine in primary and secondary forms of human hypertension.
Hypertension. 1993;21:929933.
9.
Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A,
Basile Fasolo C, Sudano I, Salvetti A. Aging and
endothelial function in normotensive subjects and
essential hypertensive patients. Circulation. 1995;91:19811987.
10.
Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I,
Bernini G, Pinto S, Salvetti A. Menopause is associated with
endothelial dysfunction in women.
Hypertension. 1996;28:576582.
11.
Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ,
Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm
resistance vessels in hypercholesterolemic humans.
J Clin Invest. 1990;86:228234.
12.
Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA.
The role of nitric-oxide in endothelium-dependent
vasodilation of hypercholesterolemic patients.
Circulation. 1993;88:25412547.
13.
Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager
MA. Impaired nitric oxide mediated vasodilation in patients with non
insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567574.[Abstract]
14.
Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P,
Creager MA. Vitamin C improves endothelium-dependent
vasodilation in patients with non-insulin-dependent diabetes mellitus.
J Clin Invest. 1996;97:2228.[Medline]
[Order article via Infotrieve]
15.
Heitzer T, Ylä-Herttuala S, Luoma J, Kurz S,
Munzel T, Just H, Olschewski M, Drexler H. Cigarette smoking
potentiates endothelial dysfunction of forearm
resistance vessels in patients with
hypercholesterolemia: role of oxidized LDL.
Circulation. 1996;93:13461353.
16.
Poli A, Tremoli E, Colombo A. Ultrasonographic
measurement of the common carotid artery wall thickness in
hypercholesterolemic patients: a new model for the
quantification and follow up of preclinical
atherosclerosis in living human subjects.
Atherosclerosis. 1988;70:253261.[Medline]
[Order article via Infotrieve]
17.
Salonen JT, Salonen R. Ultrasonographically assessed
carotid morphology and the risk of coronary heart disease.
Arterioscler Thromb. 1991;11:12451249.
18.
Crouse JR III, Craven TE, Hagaman AP, Bond G.
Association of coronary disease with segment specific
intimal-medial thickening of the extracranial carotid artery.
Circulation. 1995;92:11411147.
19.
Borhani NO, Mercuri M, Borhani PA, Buckalew VM,
Canossa-Terris M, Carr AA, Kappadoga T, Rocco MV, Schnaper HW, Sowers
JR, Bond G. Final outcome results of the multicenter isradipine
diuretic atherosclerosis study (MIDAS).
JAMA. 1996;276:785791.
20.
Devereux RB, Alonso DR, Lertas EM, Gottlib GJ, Campo E,
Sachs I, Reichek N. Echocardiographic assessment of
left ventricular mass: comparison to necropsy findings.
Am J Cardiol. 1986;57:450458.[Medline]
[Order article via Infotrieve]
21.
Whitney RJ. The measurement of volume changes in human
limbs. J Physiol (Lond). 1953;121:127.
22.
Pedrinelli R, Taddei S, Graziadei L, Salvetti A.
Vascular responses to ouabain and norepinephrine in low and
normal renin hypertension. Hypertension. 1986;8:786792.
23.
Schultz KD, Schultz K, Schultz G. Sodium nitroprusside
and other smooth muscle relaxants increase cyclic GMP levels in rat
ductus deferens. Nature. 1977;265:750751.[Medline]
[Order article via Infotrieve]
24.
Pedrinelli R, Taddei S, Spessot M, Salvetti A. Maximal
postischemic forearm vasodilation in human hypertension: a
reassessment of the method. J Hypertens. 1987;5(suppl
5):S431S433.
25.
Agabiti-Rosei E, Rizzoni D, Castellano M, Porteri E,
Zulli R, Muiesan ML, Bettoni G, Salvetti M, Muiesan P, Giulini SM.
Media:lumen ratio in human small resistance arteries is related to
forearm minimal vascular resistance. J Hypertens. 1995;13:341347.[Medline]
[Order article via Infotrieve]
26.
Schiffrin LE, Deng LY. Structure and function of
resistance arteries of hypertensive patients treated with a
ß-blocker or a calcium channel antagonist.
J Hypertens. 1996;14:12471255.[Medline]
[Order article via Infotrieve]
27.
Folkow B. The structural factor in hypertension with
special emphasis on the altered geometric design of the systemic
arteries. In: Laragh JH, Brenner BM, eds. Hypertension:
Pathophysiology, Diagnosis and Treatment. New York, NY: Raven
Press Publishers; 1995:481502.
28.
Devereux RB, Pickering TG, Harshfield GA,
Kleinert HD, Denby L, Clark L, Pregibon B, Jason M, Kleiner B, Borer
JS, Laragh JH. Left ventricular hypertrophy in
patients with hypertension: importance of blood pressure response to
regularly recurring stress. Circulation. 1983;68:15501558.
29.
Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli
R, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effects of
long-term antihypertensive treatment with lisinopril on
resistance arteries in hypertensive patients with left
ventricular hypertrophy. J
Hypertens. 1997;15:197204.[Medline]
[Order article via Infotrieve]
30.
Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I,
Salvetti A. Defective L-arginine-nitric oxide pathway in
offspring of essential hypertensive patients. Circulation. 1996;94:12981303.
31.
Panza JA, Quyyumi AA, Callahan TS, Epstein SE.
Effect of antihypertensive treatment on
endothelium-dependent vascular relaxation in patients
with essential hypertension. J Am Coll Cardiol. 1993;21:11451151.[Abstract]
32.
Creager MA, Roddy MA. Effect of captopril and enalapril
on endothelial function in hypertensive patients.
Hypertension. 1994;24:499505.
33.
Kiowski W, Linder L, Nuesch R, Martina B. Effect of
cilazapril on vascular structure and function in essential
hypertension. Hypertension. 1996;27(pt 1):371376.
34.
Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG,
Rosen S, Alderman MH, Devereux RB. Parallel cardiac and vascular
adaptation in hypertension. Circulation. 1992;86:19091918.
35.
Cuspidi C, Lonati L, Sampieri L, Pellizzoli S,
Pontiggia G, Leonetti G, Zanchetti A. Left ventricular
concentric remodeling and carotid structural changes in essential
hypertension. J Hypertens. 1996;14:14411446.[Medline]
[Order article via Infotrieve]
36.
Gariepy J, Simon A, Massonneau M, Linhart A, Segond P,
Levenson J, Groupe PCVMETRA. Echographic assessment of carotid and
femoral arterial structure in man with essential
hypertension. Am J Hypertens. 1996;9:126136.[Medline]
[Order article via Infotrieve]
37.
Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of
endothelium-derived nitric oxide in the abnormal
endothelium-dependent vascular relaxation of patients
with essential hypertension. Circulation. 1993;87:14681474.
38.
Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A.
Cyclooxygenase inhibition restores nitric oxide
activity in essential hypertension. Hypertension. 1997;29(pt
2):274279.
39.
Radomski MW, Palmer RMJ, Moncada S.
Endogenous nitric oxide inhibits human platelet
adhesion to vascular endothelium. Lancet. 1987;2:10571068.[Medline]
[Order article via Infotrieve]
40.
Garg UC, Hassid A. Nitric oxide-generating vasodilators
and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and
proliferation of cultured rat vascular smooth muscle cells.
J Clin Invest. 1989;83:17741777.
41.
Dubey RK, Ganten D, Lüscher TF. Enhanced
migration of smooth muscle cells from Ren-2 transgenic rats in response
to angiotensin II: inhibition by nitric oxide. Hypertension. 1993;22:412. Abstract.
42.
Kubes P, Suzuki M, Granger DN. Nitric oxide: an
endogenous modulator of leucocyte adhesion. Proc Natl
Acad Sci U S A. 1991;88:46514655.
43.
De Caterina R, Libby P, Peng HB, Thannichal VJ,
Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases
cytokine-induced endothelial activation.
J Clin Invest. 1995;96:6068.
44.
Shirahase H, Fujiwara M, Usui H, Kurahashi K. A
possible role of thromboxane A2 in
endothelium in maintaining resting tone and producing
contractile response to acetylcholine and arachidonic
acid in canine cerebral arteries. Blood Vessels. 1987;24:117119.[Medline]
[Order article via Infotrieve]
45.
Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion
is involved in the breakdown of endothelium-derived
vascular relaxing factor. Nature. 1986;320:454456.[Medline]
[Order article via Infotrieve]
46.
Alexander RW. Hypertension and the pathogenesis of
atherosclerosis. Hypertension. 1995;25:155161.
47.
Clozel M, Kuhn H, Hefti F, Baumgartner HR.
Endothelial dysfunction and
subendothelial monocyte macrophages in
hypertension: effect of angiotensin converting enzyme
inhibition. Hypertension. 1991;18:132141.
48.
Taddei S, Virdis A, Mattei P, Ghiadoni L, Basile Fasolo
C, Sudano I, Salvetti A. Hypertension causes premature aging of
endothelial function in humans.
Hypertension. 1997;29:736743.
49.
Folsom AR, Wu KK, Shahar E, Davis CE, for the
Atherosclerosis Risk in Communities (ARIC) Study
Investigators. Association of homeostatic variables with prevalent
cardiovascular disease and asymptomatic
carotid artery atherosclerosis. Arterioscler
Thromb. 1993;13:18291836.
50.
Folsom AR, Eckfeldt JH, Weitman S, Ma J, Chambless LE,
Barnes RW, Cram KB, Hutchinson RG, for the
Atherosclerosis Risk in Communities (ARIC) Study
Investigators. Relation of carotid artery wall thickness to diabetes
mellitus, fasting glucose and insulin, body size, and physical
activity. Stroke. 1994;25:6673.[Abstract]
© 1998 American Heart Association, Inc.
Scientific Contributions
Endothelial Function and Common Carotid Artery Wall Thickening in Patients With Essential Hypertension
![]()
Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References
AbstractIntimal-medial thickening
of the carotid wall is considered an early marker of
atherosclerosis. Endothelial function
is impaired in the presence of various cardiovascular
risk factors that are implicated in the pathogenesis of
atherosclerosis. To evaluate the relationship between
vascular reactivity and carotid intimal-medial thickening, in 44
(mean±SD age, 45.7±8.8 years; range, 28 to 60 years; 31 men and 13
women) patients with essential hypertension who had never been treated
and whose history of increased blood pressure was no longer than 12
months, we evaluated several parameters: intimal-medial
thickening of the common carotid arteries (by B-mode ultrasound);
forearm vascular response (by strain-gauge plethysmography) to
intrabrachial infusion of acetylcholine (0.15, 0.45, 1.5, 4.5, and 15
µg/100 mL forearm tissue per minute), an
endothelium-dependent vasodilator, or sodium
nitroprusside (1, 2, and 4 µg/100 mL forearm tissue per minute), an
endothelium-independent vasodilator; calculated minimal
forearm vascular resistances (the ratio between mean
arterial pressure and maximal forearm vasodilation induced
by 13 minutes of ischemia and 1 minute of exercise); and left
ventricular mass index (on
echocardiography profile). Carotid wall
intimal-medial thickening showed a significant
(P<0.001) inverse correlation with vasodilation to
acetylcholine (r=-0.58) and age
(r=-0.40), whereas no correlation was observed with the
response to sodium nitroprusside or with minimal forearm vascular
resistances, left ventricular mass index, systolic
and diastolic blood pressures, and plasma
cholesterol and glucose levels. Moreover, vasodilation to
acetylcholine showed no correlation with minimal forearm vascular
resistances or left ventricular mass index. Although
comparison of different vascular "districts," such as the forearm
microcirculation and carotid artery, does not allow for a conclusive
interpretation, the present data indicate that in patients with
essential hypertension, carotid wall thickening is associated with
reduced endothelium-dependent vasodilation and suggest
that endothelial dysfunction might be involved in early
arterial structural alterations.
Key Words: endothelium carotid arteries hypertension, essential acetylcholine sodium nitroprusside
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
Although essential
hypertension is defined as a genetic disease characterized by
consistently elevated BP values, its clinical relevance arises
from the associated increased predisposition to
cardiovascular morbidity and
mortality.1 Probably the most important mechanism
by which essential hypertension acts as a
cardiovascular risk factor is the induction of
atherosclerosis.1 However, the
pathological events leading from high BP to atherosclerotic lesions are
still to be fully clarified.
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
Patients
The study population included 30 normotensive subjects (20 men
and 10 women) and 44 patients with essential hypertension (31 men and
13 women). Subjects with marked
hypercholesterolemia (total
cholesterol >6.2 mmol/L), a heavy smoking habit (>10
cigarettes/d), diabetes mellitus, cardiac or cerebral ischemic
vascular disease, impaired renal function, and other major pathologies
were excluded from the study. In accordance with institutional
guidelines, the protocol was approved by the ethics committee of the
University of Pisa. All patients were aware of the investigational
nature of the study and gave their written consent.
Ach HCl (Farmigea SpA) and SNP (Malesci) were obtained from
commercially available sources and freshly diluted to the desired
concentration by adding normal saline. SNP was dissolved in glucosate
solution and protected from light with aluminum foil.
Each subject underwent the following examinations: B-mode
ultrasound imaging of the carotid artery,
echocardiographic examination, and FBF studies.
High-resolution B-mode ultrasound examination of the carotid
arteries was performed with a Biosound 2000 IISA with a 7.5-MHz
transducer. Sonography and readings were carried out by trained and
certified sonographers with regular quality-control checks (Division of
Vascular Ultrasound Research, Bowman Gray School of Medicine of Wake
Forest University), as previously described by Crouse et
al.18 Patients were examined in the supine
position, and each carotid wall and segment was examined independently
from continuous angles to identify the thickest intimal-medial site.
Each scan of the common carotid artery began just above the clavicle,
and the transducer was moved cephalad past the bifurcation and
along the internal carotid artery. Three segments were identified on
each side: the distal 1.0 cm of the common carotid proximal to the
bifurcation, the bifurcation itself, and the proximal 1.0 cm of the
internal carotid artery. At each of the three segments for both near
and far walls in the left and right carotid arteries, the sonographer
identified two interfaces: on the near wall, the first interface
(interface 2) was the adventitial-medial boundary, and the second
(interface 3), the intimal-luminal boundary; on the far wall, the first
interface (interface 4) was the luminal-intimal boundary, and the
second (interface 5), the medial-adventitial boundary. Thus, the
distances between interfaces 2 and 3 and between 4 and 5 define
the IMTs on the near and far walls, respectively. When these
interfaces had been imaged distinctly, the sonographer reduced the gain
and time-gain control settings to as low as possible to decrease
artifacts; the video images that included the maximum near- and
far-wall IMTs at each of the 12 segments were then recorded. Images
were transcribed onto SVHS 1/2-in. videotape. Frames that
identified the maximum near- and far-wall IMTs within each segment were
interfaced to a high-resolution monitor, and maximum wall
diastolic (minimal carotid diameter) thickness was
calculated at each site. Under our experimental conditions, the
variability of measurements was 7.9±0.3%. For this study, the mean of
the aggregate of all 12 sites and the maximum of all 12 sites were
calculated. Because of the highly significant correlation between these
two parameters (r=0.83, P<0.0001),
the analysis was performed with only the maximum thickness of
all 12 sites.
Echocardiograms (SIM 500, Esaote Biomedica) were performed from
parasternal and apical windows with the subjects in the left lateral
decubitus position. An ECG tracing with an easily discernible QRS
complex was chosen. The dimensions of the left ventricle, septum, and
posterior wall were obtained at the beginning of the QRS complex, with
the ultrasound beam passing through the left ventricle at the level of
the tips of the mitral valve leaflets. Following the recommendations of
the Penn Convention, we measured (in centimeters) the
diastolic thickness of the left
interventricular septum and left ventricular
posterior wall, as well as the diastolic dimension of the
left ventricular chamber; these measurements were inserted
into the mathematical model for the prediction of LVMI according to
Devereux et al.20 The operator (V.D.L.) was
blinded with respect to the results of other evaluations.
All studies were performed at 8 AM after an
overnight fast, with the subjects lying supine in a quiet,
air-conditioned room (22°C to 24°C). A polyethylene cannula (21
gauge, Abbot) was inserted into the brachial artery under local
anesthesia (2% lidocaine) and connected through stopcocks
to a pressure transducer (model MS20, Electromedics) for systemic mean
BP (1/3 pulse pressure+diastolic pressure) and heart rate
(model VSM1, Physiocontrol) monitoring and for
intra-arterial infusions. FBF was measured in both forearms
(experimental and contralateral forearm) by strain-gauge venous
plethysmography (LOOSCO, GL LOOS).21 Circulation
to the hand was excluded 1 minute before FBF measurement by inflating a
pediatric cuff around the wrist at suprasystolic blood
pressure. Details concerning the sensitivity and reproducibility of the
method as performed in our laboratory have already been
published.22
Results are expressed as mean±SD. Differences between means in
Table 1
were analyzed by
Student's t test for unpaired data. FBF data were
analyzed as absolute values by ANOVA for repeated measures;
Scheffé's test was applied for multiple comparison testing.
Differences were considered statistically significant at
P<0.05.
View this table:
[in a new window]
Table 1. Characteristics of Study Subjects
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
References
The baseline systemic demographic, hemodynamic,
and humoral characteristics for normotensive subjects and essential
hypertension patients are summarized in Table 1
. No difference was
found between the two groups, with the exclusion of BP values. The mean
carotid maximal IMT was 1.0±0.1 mm in normotensive subjects and
1.2±0.3 in essential hypertension patients (P<0.01 versus
normotensives). According to the results of the carotid scanning,
hypertensive patients were divided into three groups: (1) n=13 patients
were found to be normal (ie, an IMT of 0.9±0.1 mm); (2) n=20
patients had IMT thickening (IMT of 1.2±0.1 mm); and (3) n=11
patients had plaque (IMT of 1.6±0.2 mm). These subgroups of
hypertensive subjects presented no differences in the
hemodynamic and humoral characteristics considered
(Table 2
).
View this table:
[in a new window]
Table 2. Demographic, Hemodynamic, and
Humoral Characteristics of Essential Hypertension Patients (n=44)
Divided Into Three Subgroups According to Carotid Wall Thickening
). In
contrast, the response to SNP was similar in controls and hypertensive
patients (FBF rose from 3.6±0.4 to 27.9±3.6 and 3.4±0.6 to 26.5±4.3
mL per 100 mL of forearm tissue per minute, respectively) (Figure 1
). When the response to Ach was also examined in the three subgroups
of hypertensive patients, it was found that
endothelium-dependent vasodilation was significantly
lower in essential hypertension patients with thickening (FBF rose from
3.4±0.5 to a maximum of 21.9±3.1 mL per 100 mL of forearm tissue per
minute) and plaque (FBF rose from 3.4±0.7 to a maximum of 17.9±3.7 mL
per 100 mL of forearm tissue per minute) than in
hypertensive patients with a normal IMT (FBF rose from
3.2±0.6 to a maximum of 29.6±5.2 mL per 100 mL of forearm tissue per
minute; P<0.05) (Figure 2
).
However, in the normal IMT subgroup, the vasodilating effect of Ach was
still lower than that in normotensive subjects (P<0.05).
The response to SNP was still similar in the three hypertensive
subgroups (for normal IMT, FBF rose from 3.4±0.5 to a maximum of
27.8±4.3; for those with thickening, FBF rose from 3.5±0.4 to a
maximum of 26.4±3.6; and for those with plaque, FBF rose from 3.6±0.6
to a maximum of 24.2±3.5 mL per 100 mL of forearm tissue per minute)
(Figure 2
). In normotensive subjects, no significant correlation was
found between carotid IMT and the response to Ach or SNP
(r=-0.10, P=NS and r=-0.08,
P=NS, respectively).

View larger version (15K):
[in a new window]
Figure 1. FBF increase above basal levels (b) induced by
intra-arterial Ach (µg per 100 mL of forearm tissue per
minute) (left) and SNP (SNP, µg per 100 mL of forearm tissue per
minute) (right) in 44 essential hypertension patients (
) and 30
normotensive subjects (
). Data are shown as mean±SD. and reported
as absolute values. Asterisks denote significant difference between
hypertensive patients and normotensive subjects
(*P<0.001).

View larger version (16K):
[in a new window]
Figure 2. FBF increase above basal levels (b) induced by
intra-arterial Ach (µg per 100 mL of forearm tissue per
minute) (left) and SNP (µg per 100 mL of forearm tissue per minute)
(right) in 44 essential hypertension patients divided into three
subgroups: patients with <1 mm IMT (
), those with IMT of 1 to
1.3 mm (
), and those with IMT >1.3 mm (
). Data are
shown as mean±SD and reported as absolute values. Asterisks denote a
significant difference between the three subgroups of hypertensive
patients (*P<0.05 or less).
), whereas no correlation was observed
with the response to SNP (FBF response to the highest infusion rate (4
µg per 100 mL of forearm tissue per minute, r=-0.06,
P=NS). Age was positively and significantly correlated with
carotid artery IMT (r=0.40, P=0.022) (Figure 3
)
and inversely and significantly with the maximal response to Ach
(r=-0.51, P=0.001).

View larger version (17K):
[in a new window]
Figure 3. Relationship between carotid wall thickening
(x axis) and age (y axis, top) and FBF
response to the highest infusion rate of Ach (15 µg per 100 mL of
forearm tissue per minute) (y axis, bottom) in 44
essential hypertension patients.
![]()
Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References
At the present time, B-mode ultrasonography is extensively
used to detect early structural changes in carotid arteries because the
thickening process in these areas is considered a prognostic marker for
the development of
atherosclerosis16 and appears to
correlate with coronary lesions.17 In the
present study, we tested the possible existence of a relationship
between early structural changes in carotid arteries and
endothelial dysfunction in essential hypertension
patients. Given the possibility that regression or induction of
cardiovascular alterations, whether structural or
functional, could be caused by long-term pharmacological treatment or
different duration of hypertension,25 26 27 28 the
present study was designed to recruit never-treated essential
hypertension patients with a sufficiently accurate determination of
disease onset. To pursue this aim, we cooperated with general
practitioners who were asked to recruit subjects known to
be undergoing measurement of BP values at least once every 6 months.
Only subjects whose documented report of high BP values was no longer
than 1 year were then enrolled.
![]()
Selected Abbreviations and Acronyms
Ach
=
acetylcholine
BP
=
blood pressure
FBF
=
forearm blood flow
IMT
=
intimal-medial thickening
LVMI
=
left ventricular mass index
MFVR
=
minimal forearm vascular resistance
SNP
=
sodium nitroprusside
![]()
References
Top
Abstract
Introduction
Methods
Results
Discussion
References
1.
Wilson PWF, Kannel WB. Hypertension, other risk
factors and the risk of cardiovascular disease. In:
Laragh JH, Brenner BM, eds. Hypertension:
Pathophysiology, Diagnosis and Treatment. New York, NY:
Raven Press Publishers; 1995:99114.
This article has been cited by other articles:
![]() |
D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease Diabetes Care, November 1, 2009; 32(suppl_2): S314 - S321. [Full Text] [PDF] |
||||
![]() |
S Lavi, J-H Bae, C S Rihal, A Prasad, G W Barsness, R J Lennon, D R Holmes Jr, and A Lerman Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques Heart, September 15, 2009; 95(18): 1525 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei The ageing endothelium, cardiovascular risk and disease in man Exp Physiol, March 1, 2009; 94(3): 317 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cupisti, L. Ghiadoni, C. D'Alessandro, I. Kardasz, E. Morelli, V. Panichi, D. Locati, S. Morandi, A. Saba, G. Barsotti, et al. Soy protein diet improves endothelial dysfunction in renal transplant patients Nephrol. Dial. Transplant., January 1, 2007; 22(1): 229 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jawa, S. Nachimuthu, M. Pendergrass, S. Asnani, and V. Fonseca Impaired Vascular Reactivity in African-American Patients with Type 2 Diabetes Mellitus and Microalbuminuria or Proteinuria Despite Angiotensin-Converting Enzyme Inhibitor Therapy J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 31 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W.J. Vriend, A. H. Zwinderman, E. de Groot, J. J.P. Kastelein, B. J. Bouma, and B. J.M. Mulder Predictive value of mild, residual descending aortic narrowing for blood pressure and vascular damage in patients after repair of aortic coarctation Eur. Heart J., January 1, 2005; 26(1): 84 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Paradossi, E. Ciofini, A. Clerico, N. Botto, A. Biagini, and M. G. Colombo Endothelial Function and Carotid Intima-Media Thickness in Young Healthy Subjects Among Endothelial Nitric Oxide Synthase Glu298->Asp and T-786->C Polymorphisms Stroke, June 1, 2004; 35(6): 1305 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ghiadoni, A. Magagna, D. Versari, I. Kardasz, Y. Huang, S. Taddei, and A. Salvetti Different Effect of Antihypertensive Drugs on Conduit Artery Endothelial Function Hypertension, June 1, 2003; 41(6): 1281 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taddei, A. Virdis, L. Ghiadoni, D. Versari, G. Salvetti, A. Magagna, and A. Salvetti Calcium Antagonist Treatment by Lercanidipine Prevents Hyperpolarization in Essential Hypertension Hypertension, April 1, 2003; 41(4): 950 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Spacil, R. Ceska, and T. Haas Flow-Dependent Vasomotor Dysfunction of the Popliteal Artery Related to Common Carotid Artery Intima-Media Thickness Angiology, October 1, 2001; 52(10): 689 - 695. [Abstract] [PDF] |
||||
![]() |
E. B. Spencer, D. H. Sheafor, B. S. Hertzberg, J. D. Bowie, R. C. Nelson, B. A. Carroll, and M. A. Kliewer Nonstenotic Internal Carotid Arteries: Effects of Age and Blood Pressure at the Time of Scanning on Doppler US Velocity Measurements Radiology, July 1, 2001; 220(1): 174 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rubenfire, S. Rajagopalan, and L. Mosca Carotid artery vasoreactivity in response to sympathetic stress correlates with coronary disease risk and is independent of wall thickness J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2192 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Toikka, H. Laine, M. Ahotupa, A. Haapanen, J. S. A. Viikari, J. J. Hartiala, and O. T Raitakari Increased Arterial Intima-Media Thickness and In Vivo LDL Oxidation in Young Men With Borderline Hypertension Hypertension, December 1, 2000; 36(6): 929 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gaeta, M. De Michele, S. Cuomo, P. Guarini, M. C. Foglia, M. G. Bond, and M. Trevisan Arterial Abnormalities in the Offspring of Patients with Premature Myocardial Infarction N. Engl. J. Med., September 21, 2000; 343(12): 840 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Virdis, L. Ghiadoni, S. Pinto, M. Lombardo, F. Petraglia, A. Gennazzani, S. Buralli, S. Taddei, and A. Salvetti Mechanisms Responsible for Endothelial Dysfunction Associated With Acute Estrogen Deprivation in Normotensive Women Circulation, May 16, 2000; 101(19): 2258 - 2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, C. D. Sigmund, F. M. Faraci, and Z. S. Katusic Impaired Endothelial Function in Transgenic Mice Expressing Both Human Renin and Human Angiotensinogen • Editorial Comment Stroke, March 1, 2000; 31(3): 760 - 765. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |